Noreen Griffin - 28 May 2021 Form 4 Insider Report for Immune Therapeutics, Inc.

Reporting relationship: Member of 10% owner group, 10%+ Owner
Issuer ticker: N/A
Reported as of: 28 May 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Jun 2021, 20:49:46 UTC
Source filing: View source filing
Reporting owner signature: /s/ Noreen Griffin

Key filing fact

Noreen Griffin filed Form 4 for Immune Therapeutics, Inc. on 04 Jun 2021.

Key facts

This page summarizes Noreen Griffin's Form 4 filing for Immune Therapeutics, Inc..
5 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 04 Jun 2021, 20:49.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IMUN transaction

Common Stock

Other

Transaction value: $0
Shares: 0
Change %: 0%
Price: $0.000000^*
Shares after: 429
Date: 28 May 2021
Ownership: Direct
Footnotes: F1

IMUN transaction

Common Stock

Other

Transaction value: $0
Shares: 0
Change %: 0%
Price: $0.000000^*
Shares after: 704
Date: 28 May 2021
Ownership: By: Griffin Enterprises Group, Inc.
Footnotes: F1, F2

IMUN transaction

Common Stock

Other

Transaction value: $0
Shares: 0
Change %: 0%
Price: $0.000000^*
Shares after: 2,685
Date: 28 May 2021
Ownership: By: Griffin Family Trust
Footnotes: F1, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IMUN transaction Derivative

Warrants (Right to Buy)

Other

Transaction value: $0
Shares: 0
Change %: 0%
Price: $0.000000^*
Shares after: 7,420
Date: 28 May 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,420
Exercise price: $5.00
Footnotes: F1

IMUN transaction Derivative

Convertible Note

Other

Transaction value: $0
Shares: 0
Change %: 0%
Price: $0.000000^*
Shares after: 49,772
Date: 28 May 2021
Ownership: By: Global Reverb Corporation
Underlying class: Common Stock
Underlying amount: 49,772
Exercise price: $5.00
Footnotes: F1, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The Reporting Person may be deemed to have entered into a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, as of May 28, 2021 in connection with the Reporting Person and the Issuer's execution of a non-binding Term Sheet as of this date in which the Reporting Person executed such Term Sheet as representative of certain other parties to the Term Sheet. The Reporting Person disclaims the existence of a "group" and disclaims beneficial ownership of any securities held by such "group" (and this report shall not be deemed an admission that any such person is the beneficial owner of any such securities), except to the extent of her pecuniary interest, if any, in such securities.

Footnote F2

50% owned by the Reporting Person and 50% owned and managed by Robert Wilson, who is the Reporting Person's son, and the Reporting Person has shared voting and dispositive power over such shares. The Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein, and the inclusion of these shares in this Form 4 shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 13 or for any other purpose.

Footnote F3

An irrevocable trust for the benefit of the Reporting Person's children and grandchildren, and the Reporting Person has shared voting and dispositive power over such shares. The Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein, and the inclusion of these shares in this Form 4 shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 13 or for any other purpose.

Footnote F4

A Florida corporation, of which Griffin is the sole officer, director and shareholder, and Griffin has sole voting and dispositive power over its securities.